Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Oaktree Acquisition Corp. II Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2022 25 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
06/09/2022 425 Form 425 - Prospectuses and communications, business combinations:
06/07/2022 425 Form 425 - Prospectuses and communications, business combinations:
06/07/2022 8-K Quarterly results
06/03/2022 425 Form 425 - Prospectuses and communications, business combinations:
06/03/2022 8-K Quarterly results
05/31/2022 425 Form 425 - Prospectuses and communications, business combinations:
05/31/2022 8-K Quarterly results
05/24/2022 425 Form 425 - Prospectuses and communications, business combinations:
05/17/2022 425 Form 425 - Prospectuses and communications, business combinations:
05/17/2022 8-K Quarterly results
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/16/2022 425 Form 425 - Prospectuses and communications, business combinations:
05/11/2022 425 Form 425 - Prospectuses and communications, business combinations:
05/10/2022 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
04/22/2022 425 Form 425 - Prospectuses and communications, business combinations:
04/22/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "First Amendment to the Business Combination Agreement, by and between Alvotech Holdings S.A. and Oaktree Acquisition Corp. II"
04/19/2022 425 Form 425 - Prospectuses and communications, business combinations:
04/18/2022 425 Form 425 - Prospectuses and communications, business combinations:
04/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/06/2022 425 Form 425 - Prospectuses and communications, business combinations:
04/06/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Alvotech and STADA pave way to launching HUKYNDRA®, a citrate-free, high-concentration biosimilar to Humira® by resolving European patent dispute with AbbVie"
03/30/2022 10-K Annual Report for the period ended December 31, 2021
03/23/2022 425 Form 425 - Prospectuses and communications, business combinations:
03/23/2022 8-K Quarterly results
03/23/2022 425 Form 425 - Prospectuses and communications, business combinations:
03/08/2022 425 Form 425 - Prospectuses and communications, business combinations:
03/08/2022 8-K Quarterly results
02/28/2022 425 Form 425 - Prospectuses and communications, business combinations:
02/23/2022 425 Form 425 - Prospectuses and communications, business combinations:
02/16/2022 SC 13G MILLENNIUM MANAGEMENT LLC reports a 5.3% stake in OAKTREE ACQUISITION CORP. II
02/14/2022 425 Form 425 - Prospectuses and communications, business combinations:
02/07/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2022 425 Form 425 - Prospectuses and communications, business combinations:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy